Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

ELJ
Entergy Louisiana LLC
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Dec 2017 29 Sep 2017 29 Jun 2017 30 Mar 2017
Current assets
Cash $35.907 $55.523 $215.283 $67.293
Short term investments
Net receivables $603.413 $703.92 $604.215 $504.977
Inventory $339.609 $340.64 $336.189 $334.578
Total current assets $1,078.675 $1,281.559 $1,393.306 $1,087.705
Long term investments $1,409.586 $2,669.446 $2,635.767 $2,604.953
Property, plant & equipment $13,031.497 $12,599.243 $12,278.52 $12,025.519
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $18,448.864 $18,598.339 $18,378.413 $17,799.878
Current liabilities
Accounts payable $531.059 $170.667 $148.624 $153.093
Deferred revenue
Short long term debt $6,187.611 $715.557 $552.196 $234.003
Total current liabilities $1,644.393 $1,481.819 $1,283.627 $943.27
Long term debt $5,469.069 $5,492.494 $5,728.309 $5,613.849
Total noncurrent liabilities
Total debt
Total liabilities $13,140.06 $13,203.751 $13,169.704 $12,666.19
Stockholders' equity
Retained earnings
Other stockholder equity -$46.4 $5,394.588 $5,208.709 $5,133.688
Total stockholder equity $5,308.804 $5,394.588 $5,208.709 $5,133.688
(in millions USD) 2017 2016 2015
Current assets
Cash $35.907 $213.85 $35.102
Short term investments
Net receivables $603.413 $576.396 $469.132
Inventory $339.609 $345.159 $330.733
Total current assets $1,078.675 $1,309.731 $930.245
Long term investments $1,409.586 $2,560.138 $2,447.656
Property, plant & equipment $13,031.497 $11,717.254 $10,840.76
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $18,448.864 $17,701.271 $16,387.447
Current liabilities
Accounts payable $531.059 $157.704 $364.941
Deferred revenue
Short long term debt $6,187.611 $203.992 $89.728
Total current liabilities $1,644.393 $997.262 $1,022.72
Long term debt $5,469.069 $5,612.593 $4,806.79
Total noncurrent liabilities
Total debt
Total liabilities $13,140.06 $12,619.462 $11,650.135
Stockholders' equity
Retained earnings
Other stockholder equity -$46.4 $5,081.809 $4,737.312
Total stockholder equity $5,308.804 $5,081.809 $4,737.312

Income statement

XSLX
XSLX
(in millions USD) 30 Dec 2017 29 Sep 2017 29 Jun 2017 30 Mar 2017
Revenue
Total revenue $1,045.839 $1,290.494 $1,083.434 $880.783
Cost of revenue $738.534 $826.774 $724.828 $623.168
Gross profit $307.305 $463.72 $358.606 $257.615
Operating activities
Research & development
Selling, general & administrative $0.3 $55.708 $54.838 -$16.781
Total operating expenses $835.514
Operating income $210.325 $290.089 $187.661 $158.766
Income from continuing operations
EBIT $210.325 $349.9 $249.698 $204.618
Income tax expense $291.539 $94.098 $56.736 $42.925
Interest expense -$70.672 $69.518 $68.483 $67.315
Net income
Net income -$88.794 $186.284 $124.479 $94.378
Income (for common shares) -$88.794 $186.284 $124.479 $94.378
(in millions USD) 2017 2016 2015
Revenue
Total revenue $4,300.55 $4,177.048 $4,417.146
Cost of revenue $2,913.304 $2,669.631 $3,022.805
Gross profit $1,387.246 $1,507.417 $1,394.341
Operating activities
Research & development
Selling, general & administrative $0.3 $256.74 $238.973
Total operating expenses $3,453.709
Operating income $846.841 $799.387 $718.332
Income from continuing operations
EBIT $846.841 $985.064 $885.204
Income tax expense $485.298 $89.734 $178.671
Interest expense -$275.988 $273.283 $259.894
Net income
Net income $316.347 $622.047 $446.639
Income (for common shares) $316.347 $622.047 $440.902

Cash flows

XSLX
XSLX
(in millions USD) 30 Dec 2017 29 Sep 2017 29 Jun 2017 30 Mar 2017
Net income -$88.794 $186.284 $124.479 $94.378
Operating activities
Depreciation $149.448 $158.158 $149.333 $151.472
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $410.369 $393.421 $194.051 $339.704
Investing activities
Capital expenditures -$502.968 -$421.963 -$394.465 -$360.693
Investments $33.324 -$59.957 -$33.353 -$18.854
Total cash flows from investing -$408.044 -$479.155 -$428.199 -$472.011
Financing activities
Dividends paid -$49.125 -$42.125
Sale and purchase of stock
Net borrowings -$21.899 -$73.873 $431.121 $30.005
Total cash flows from financing -$21.941 -$74.026 $382.138 -$14.25
Effect of exchange rate
Change in cash and equivalents -$19.616 -$159.76 $147.99 -$146.557
(in millions USD) 2017 2016 2015
Net income $316.347 $622.047 $446.639
Operating activities
Depreciation $571.561 $620.211 $593.635
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $1,337.545 $1,037.912 $1,155.516
Investing activities
Capital expenditures -$1,776.35 -$1,505.086 -$845.227
Investments -$55.439 -$37.893
Total cash flows from investing -$1,787.409 -$1,474.065 -$994.208
Financing activities
Dividends paid -$91.25 -$285.5 -$232.082
Sale and purchase of stock -$110.286
Net borrowings $365.354 $904.631 -$89.101
Total cash flows from financing $271.921 $614.901 -$446.722
Effect of exchange rate
Change in cash and equivalents -$177.943 $178.748 -$285.414

CXDC
China XD Plastics Co Ltd
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Current assets
Cash $183.334428 $385.205458 $290.796634 $190.433854
Short term investments
Net receivables $424.888337 $149.80276 $184.384982 $240.122877
Inventory $577.935234 $749.370184 $678.543004 $630.11347
Total current assets $1,344.760833 $1,650.722618 $1,559.142766 $1,302.417152
Long term investments $242.100096
Property, plant & equipment $823.700349 $900.677561 $856.884103 $864.316943
Goodwill & intangible assets
Total noncurrent assets $1,579.165167 $1,362.160865 $1,359.670313 $1,366.560004
Total investments $242.100096
Total assets $2,923.926 $3,012.883483 $2,918.813079 $2,668.977156
Current liabilities
Accounts payable $437.356298 $434.660878 $405.187066 $450.011831
Deferred revenue $105.943812 $90.559854 $88.298695 $90.031695
Short long term debt $644.925707 $797.139254 $772.356912 $674.145237
Total current liabilities $1,230.282394 $1,343.19562 $1,282.324759 $1,268.285841
Long term debt $741.385817 $617.109684 $589.702224 $359.492121
Total noncurrent liabilities $926.429369 $792.355393 $759.846945 $587.939108
Total debt $1,386.311524 $1,414.248938 $1,362.059136 $1,033.637358
Total liabilities $2,156.711763 $2,135.551013 $2,042.171704 $1,856.224949
Stockholders' equity
Retained earnings $538.357103 $688.463772 $726.696685 $709.120874
Other stockholder equity -$9.479166 -$47.48972 -$80.085057 -$80.491217
Total stockholder equity $717.189087 $829.285202 $830.734178 $812.752207
(in millions USD) 2020 2019 2018
Current assets
Cash $183.334428 $228.433019 $366.99184
Short term investments
Net receivables $424.888337 $222.072053 $294.688288
Inventory $577.935234 $642.509534 $620.033195
Total current assets $1,344.760833 $1,264.862728 $1,413.931851
Long term investments $242.100096
Property, plant & equipment $823.700349 $874.469671 $775.94128
Goodwill & intangible assets $29.796795
Total noncurrent assets $1,579.165167 $1,371.01952 $1,339.58738
Total investments $242.100096
Total assets $2,923.926 $2,635.882248 $2,753.519231
Current liabilities
Accounts payable $437.356298 $484.381655 $721.49066
Deferred revenue $105.943812 $92.63962 $99.583477
Short long term debt $644.925707 $681.563414 $729.66692
Total current liabilities $1,230.282394 $1,278.954294 $1,594.059845
Long term debt $741.385817 $336.885847 $111.808244
Total noncurrent liabilities $926.429369 $520.553843 $312.965493
Total debt $1,386.311524 $1,018.449261 $841.475164
Total liabilities $2,156.711763 $1,799.508137 $1,907.025338
Stockholders' equity
Retained earnings $538.357103 $720.159368 $717.10389
Other stockholder equity -$9.479166 -$67.907807 -$54.732547
Total stockholder equity $717.189087 $836.374111 $748.917428

Income statement

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Revenue
Total revenue $593.785201 $290.054815 $283.223987 $144.837678
Cost of revenue $529.75849 $255.491692 $243.332297 $139.599821
Gross profit $64.026711 $34.563123 $39.89169 $5.237857
Operating activities
Research & development $8.460952 $4.388573 $5.803128 $3.841792
Selling, general & administrative $12.476666 $11.331492 $3.723179 $6.146037
Total operating expenses $181.934445 $44.31241 $9.526307 $9.987829
Operating income -$117.907734 -$9.749287 $30.365383 -$4.749972
Income from continuing operations
EBIT -$130.554585 -$13.682891 $31.605365 $7.766726
Income tax expense $5.132116 $1.623473 -$1.88499 $0.889031
Interest expense $14.419968 $22.926549 $15.914544 $17.916189
Net income
Net income -$150.106669 -$38.232913 $17.575811 -$11.038494
Income (for common shares) -$150.106669 -$38.232913 $17.575811 -$11.038494
(in millions USD) 2020 2019 2018
Revenue
Total revenue $1,311.901681 $1,448.204826 $1,274.833282
Cost of revenue $1,168.1823 $1,228.809155 $1,055.220493
Gross profit $143.719381 $219.395671 $219.612789
Operating activities
Research & development $22.494445 $50.329809 $60.576574
Selling, general & administrative $33.677374 $36.836142 $47.054671
Total operating expenses $245.760991 $149.977076 $107.631245
Operating income -$102.04161 $69.418595 $111.981544
Income from continuing operations
EBIT -$104.865385 $84.334817 $127.058269
Income tax expense $5.75963 $14.036698 $7.713113
Interest expense $71.17725 $67.242641 $51.031735
Net income
Net income -$181.802265 $3.055478 $68.313421
Income (for common shares) -$181.802265 $3.055478 $68.313421

Cash flows

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Net income -$150.106669 -$38.232913 $17.575811 -$11.038494
Operating activities
Depreciation $62.536351
Business acquisitions & disposals
Stock-based compensation $4.1886
Total cash flows from operations $231.67528 $76.126444 -$221.6622 -$89.161481
Investing activities
Capital expenditures -$184.149287 $4.173357 -$4.672015 -$20.075023
Investments $195.963439 -$72.151747 -$123.811692
Total cash flows from investing -$214.610408 -$67.97839 -$128.483707 -$20.075023
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$22.42758 $0.530865 $326.818383 $27.52158
Total cash flows from financing -$15.31547 $0.887293 $327.586656 $74.143299
Effect of exchange rate -$2.448643 $7.091723 $0.031996 -$2.90596
Change in cash and equivalents -$0.699241 $16.12707 -$22.527255 -$37.999165
(in millions USD) 2020 2019 2018
Net income -$181.802265 $3.055478 $68.313421
Operating activities
Depreciation $62.536351 $60.663133 $46.282307
Business acquisitions & disposals $7.282029 $11.751535
Stock-based compensation $4.1886 $3.353811
Total cash flows from operations -$3.021957 -$189.928239 $61.393255
Investing activities
Capital expenditures -$204.722968 -$138.412642 -$308.256648
Investments $284.547929
Total cash flows from investing -$431.147528 -$130.123203 -$1.675962
Financing activities
Dividends paid
Sale and purchase of stock $0.12
Net borrowings $332.443248 $100.999856 -$20.04643
Total cash flows from financing $387.301778 $185.869389 $2.218817
Effect of exchange rate $1.769116 -$4.376768 -$15.035935
Change in cash and equivalents -$45.098591 -$138.558821 $46.900175

GNCA
Genocea Biosciences Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Current assets
Cash $20.768 $37.779 $49.539 $61.03
Short term investments
Net receivables
Inventory
Total current assets $24.408 $41.822 $50.614 $62.913
Long term investments
Property, plant & equipment $13.496 $13.261 $13.42 $13.585
Goodwill & intangible assets
Total noncurrent assets $14.38 $14.145 $14.304 $14.47
Total investments
Total assets $38.788 $55.967 $64.918 $77.383
Current liabilities
Accounts payable $0.594 $0.5 $0.978 $1.362
Deferred revenue $1.564 $1.7 $1.641
Short long term debt $7.112 $6.987 $6.865 $5.501
Total current liabilities $18.03 $18.683 $14.704 $14.832
Long term debt $8.373 $10.198 $11.987 $13.749
Total noncurrent liabilities $8.373 $10.209 $12.385 $58.496
Total debt $15.485 $17.185 $18.852 $19.25
Total liabilities $26.403 $28.892 $27.089 $73.328
Stockholders' equity
Retained earnings -$423.842 -$407.864 -$394.584 -$390.962
Other stockholder equity
Total stockholder equity $12.385 $27.075 $37.829 $4.055
(in millions USD) 2021 2020 2019
Current assets
Cash $37.779 $80.4 $40.758
Short term investments
Net receivables
Inventory
Total current assets $41.822 $82.227 $41.584
Long term investments
Property, plant & equipment $13.261 $14.431 $8.923
Goodwill & intangible assets
Total noncurrent assets $14.145 $16.266 $11.027
Total investments
Total assets $55.967 $98.493 $52.611
Current liabilities
Accounts payable $0.5 $0.534 $0.553
Deferred revenue $1.7 $1.641
Short long term debt $6.987 $15.476 $1.117
Total current liabilities $18.683 $24.995 $6.281
Long term debt $10.198 $8.398 $18.802
Total noncurrent liabilities $10.209 $64.516 $21.288
Total debt $17.185 $23.874 $19.919
Total liabilities $28.892 $89.511 $27.569
Stockholders' equity
Retained earnings -$407.864 -$374.668 -$330.954
Other stockholder equity
Total stockholder equity $27.075 $8.982 $25.042

Income statement

XSLX
XSLX
(in millions USD) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Revenue
Total revenue $0.27 $1.641
Cost of revenue
Gross profit $0.27 $1.641
Operating activities
Research & development $12.444 $10.283 $9.473 $10.513
Selling, general & administrative $3.599 $3.126 $3.884 $4.033
Total operating expenses $16.043 $13.409 $13.357 $14.546
Operating income -$15.773 -$13.409 -$11.716 -$14.546
Income from continuing operations
EBIT -$15.978 -$13.01 -$3.332 -$4.029
Income tax expense
Interest expense $0.27 $0.29 $0.282
Net income
Net income -$15.978 -$13.28 -$3.622 -$4.311
Income (for common shares) -$15.978 -$13.28 -$3.622 -$4.311
(in millions USD) 2021 2020 2019
Revenue
Total revenue $1.641 $1.359
Cost of revenue
Gross profit $1.641 $1.359
Operating activities
Research & development $39.02 $33.96 $26.952
Selling, general & administrative $14.714 $14.388 $12.037
Total operating expenses $53.734 $48.348 $38.989
Operating income -$52.093 -$46.989 -$38.989
Income from continuing operations
EBIT -$32.075 -$42.334 -$38.004
Income tax expense
Interest expense $1.121 $1.38 $0.946
Net income
Net income -$33.196 -$43.714 -$38.95
Income (for common shares) -$33.196 -$43.714 -$38.95

Cash flows

XSLX
XSLX
(in millions USD) 31 Mar 2022 31 Dec 2021 30 Sep 2021 30 Jun 2021
Net income -$15.978 -$13.28 -$3.622 -$4.311
Operating activities
Depreciation $0.4 $0.408 $0.397 $0.371
Business acquisitions & disposals
Stock-based compensation $0.901 $1.011 $1.03 $1.014
Total cash flows from operations -$15.209 -$11.105 -$11.36 -$10.512
Investing activities
Capital expenditures -$0.939 -$0.92 -$0.53 -$0.714
Investments
Total cash flows from investing -$0.939 -$0.92 -$0.53 -$0.714
Financing activities
Dividends paid
Sale and purchase of stock $0.387 $1.515 $0.399 $5.59
Net borrowings -$1.25 -$1.25
Total cash flows from financing -$0.863 $0.265 $0.399 $5.59
Effect of exchange rate
Change in cash and equivalents -$17.011 -$11.76 -$11.491 -$5.636
(in millions USD) 2021 2020 2019
Net income -$33.196 -$43.714 -$38.95
Operating activities
Depreciation $1.557 $1.138 $1.097
Business acquisitions & disposals
Stock-based compensation $3.635 $1.974 $1.837
Total cash flows from operations -$45.37 -$41.651 -$37.734
Investing activities
Capital expenditures -$3.208 -$2.555 -$1.087
Investments
Total cash flows from investing -$3.208 -$2.555 -$1.087
Financing activities
Dividends paid
Sale and purchase of stock $11.567 $83.982 $54.82
Net borrowings -$5.61 -$0.134 -$1.919
Total cash flows from financing $5.957 $83.848 $52.901
Effect of exchange rate
Change in cash and equivalents -$42.621 $39.642 $14.08

HALL
Hallmark Financial Services, Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Current assets
Cash $86.696 $165.309 $114.566 $88.619
Short term investments
Net receivables $650.694 $644.693 $720.498 $727.465
Inventory
Total current assets
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments $287.443 $318.524 $362.446 $454.796
Total assets $1,092.922 $1,249.348 $1,470.265 $1,536.702
Current liabilities
Accounts payable $167.654 $189.822 $211.408 $197.485
Deferred revenue $107.574 $156.394 $294.019 $292.691
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $105.475 $105.437 $105.4 $105.363
Total liabilities $1,100.69 $1,236.963 $1,446.73 $1,476.408
Stockholders' equity
Retained earnings -$105.454 -$84.458 -$72.549 -$33.407
Other stockholder equity -$4.68 -$5.489 -$6.206 -$8.492
Total stockholder equity -$7.768 $12.385 $23.535 $60.294
(in millions USD) 2022 2021 2020
Current assets
Cash $88.619 $356.677 $108.308
Short term investments
Net receivables $727.465 $648.825 $617.443
Inventory
Total current assets
Long term investments
Property, plant & equipment
Goodwill & intangible assets $0.819 $1.322
Total noncurrent assets
Total investments $454.796 $338.768 $536.667
Total assets $1,536.702 $1,553.598 $1,485.533
Current liabilities
Accounts payable $197.485 $171.582 $97.115
Deferred revenue $292.691 $284.427 $320.806
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $105.363 $105.213 $105.063
Total liabilities $1,476.408 $1,378.077 $1,314.611
Stockholders' equity
Retained earnings -$33.407 $74.703 $68.915
Other stockholder equity -$8.492 -$1.035 $0.383
Total stockholder equity $60.294 $175.521 $170.922

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $41.899 $41.91 $39.831 $42.305
Cost of revenue $39.473 $36.752 $29.764 $48.002
Gross profit $2.426 $5.158 $10.067 -$5.697
Operating activities
Research & development
Selling, general & administrative $16.595 $21.138 $47.949 $19.925
Total operating expenses $16.595 $21.138 $47.949 $19.929
Operating income -$14.169 -$15.98 -$37.882 -$25.626
Income from continuing operations
EBIT -$19.016 -$10.104 -$37.778 -$2.963
Income tax expense $0.456 -$0.133 -$0.534 $2.614
Interest expense $2.036 $1.938 $1.898 $1.744
Net income
Net income -$21.508 -$11.909 -$39.142 -$7.321
Income (for common shares) -$21.508 -$11.909 -$39.142 -$7.321
(in millions USD) 2022 2021 2020
Revenue
Total revenue $159.918 $404.703 $478.745
Cost of revenue $209.17 $275.244 $412.851
Gross profit -$49.252 $129.459 $65.894
Operating activities
Research & development
Selling, general & administrative $71.892 $112.467 $126.266
Total operating expenses $71.917 $112.971 $174.73
Operating income -$121.169 $16.488 -$108.836
Income from continuing operations
EBIT -$94.352 $16.488 -$108.836
Income tax expense $7.856 $2.491 -$22.507
Interest expense $5.902 $4.993 $5.326
Net income
Net income -$108.11 $9.004 -$91.655
Income (for common shares) -$108.11 $9.004 -$91.655

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$21.508 -$11.909 -$39.142 -$7.321
Operating activities
Depreciation $0.44 $0.424 $0.395 -$0.302
Business acquisitions & disposals
Stock-based compensation $0.034 $0.042 $0.097 $0.107
Total cash flows from operations -$109.111 -$4.072 -$58.896 -$90.801
Investing activities
Capital expenditures -$0.023 -$0.411 -$0.238 -$0.05
Investments $30.521 $55.226 $85.081 $7.634
Total cash flows from investing $30.498 $54.815 $84.843 $41.107
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents -$78.613 $50.743 $25.947 -$49.694
(in millions USD) 2022 2021 2020
Net income -$108.11 $9.004 -$91.655
Operating activities
Depreciation $2.021 $3.43 $5.754
Business acquisitions & disposals
Stock-based compensation $0.34 $0.229 -$0.4
Total cash flows from operations -$164.957 $43.768 -$69.327
Investing activities
Capital expenditures -$2.198 -$1.91 -$1.667
Investments -$134.426 $206.511 $124.354
Total cash flows from investing -$103.101 $204.601 $122.687
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents -$268.058 $248.369 $53.36

KGJI
Kingold Jewelry Inc
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Sep 2019 30 Jun 2019 31 Mar 2019 31 Dec 2018
Current assets
Cash $15.283597 $129.060883 $16.631506 $5.031576
Short term investments $2,518.397979 $2,215.449367 $2,174.07695 $1,593.557391
Net receivables $0.654455 $0.264158 $0.451059
Inventory $268.2143 $262.76362 $163.848955 $127.034673
Total current assets $3,045.549986 $2,866.554611 $2,632.680342 $1,985.744613
Long term investments $268.85872 $248.69714 $234.08878 $707.992268
Property, plant & equipment $4.420547 $4.924793 $5.104757 $5.39533
Goodwill & intangible assets $0.373324 $0.390837 $0.402673 $0.395719
Total noncurrent assets $274.112115 $254.505407 $240.115505 $714.069085
Total investments $2,787.256699 $2,464.146507 $2,408.16573 $2,301.549659
Total assets $3,319.662101 $3,121.060018 $2,872.795847 $2,699.813698
Current liabilities
Accounts payable $4.410957 $4.383039 $4.164872 $15.749564
Deferred revenue
Short long term debt $1,494.111845 $1,605.122197 $1,674.814595 $1,107.647553
Total current liabilities $1,536.706539 $1,645.465755 $1,712.88968 $1,148.455158
Long term debt $702.335976 $594.448691 $514.976062 $888.804882
Total noncurrent liabilities $829.991281 $666.008897 $527.949779 $913.023793
Total debt $2,196.447821 $2,199.570888 $2,189.790657 $1,996.452435
Total liabilities $2,366.69782 $2,311.474652 $2,240.839459 $2,061.478951
Stockholders' equity
Retained earnings $349.146177 $373.150634 $360.561447 $354.180868
Other stockholder equity $379.386663 $212.070348 $47.030557 $59.794859
Total stockholder equity $952.964281 $809.585366 $631.956388 $638.334747
(in millions USD) 2018 2017 2016
Current assets
Cash $5.031576 $10.531676 $74.11945
Short term investments $1,593.557391 $1,562.943153 $281.895403
Net receivables $0.451059 $0.768167 $0.670878
Inventory $127.034673 $135.042713 $119.435595
Total current assets $1,985.744613 $2,063.119059 $752.985062
Long term investments $707.992268 $964.516988 $1,501.496724
Property, plant & equipment $5.39533 $7.299643 $7.224698
Goodwill & intangible assets $0.395719 $0.429915 $0.413662
Total noncurrent assets $714.069085 $979.226293 $1,509.418087
Total investments $2,301.549659 $2,527.460141 $1,783.392127
Total assets $2,699.813698 $3,042.345352 $2,262.403149
Current liabilities
Accounts payable $15.749564 $21.544164 $20.939793
Deferred revenue
Short long term debt $1,107.647553 $1,269.491393 $263.490196
Total current liabilities $1,148.455158 $1,294.859762 $293.116111
Long term debt $888.804882 $1,357.253203 $1,685.547129
Total noncurrent liabilities $913.023793 $1,357.253203 $1,686.796751
Total debt $1,996.452435 $2,626.744596 $1,949.037325
Total liabilities $2,061.478951 $2,652.112965 $1,979.912862
Stockholders' equity
Retained earnings $354.180868 $304.634154 $278.441502
Other stockholder equity $59.794859 $5.154671 -$76.248201
Total stockholder equity $638.334747 $390.232387 $282.490287

Income statement

XSLX
XSLX
(in millions USD) 30 Sep 2019 30 Jun 2019 31 Mar 2019 31 Dec 2018
Revenue
Total revenue $382.790132 $598.008324 $453.5391 $631.174702
Cost of revenue $367.618629 $528.476748 $398.237634 $556.114612
Gross profit $15.171503 $69.531576 $55.301466 $75.06009
Operating activities
Research & development
Selling, general & administrative $2.265898 $6.733404 $2.618192 $3.96674
Total operating expenses $2.381526 $6.84001 $2.730636 $4.144705
Operating income $12.789977 $62.691566 $52.57083 $70.915385
Income from continuing operations
EBIT $13.061281 $62.990065 $52.909443 $71.293558
Income tax expense -$7.845329 $4.359554 $2.228759 $17.998378
Interest expense $44.911067 $46.041324 $44.300105 $43.794691
Net income
Net income -$24.004457 $12.589187 $6.380579 $9.500489
Income (for common shares) -$24.004457 $12.589187 $6.380579 $9.500489
(in millions USD) 2018 2017 2016
Revenue
Total revenue $2,475.666092 $2,009.732643 $1,420.62497
Cost of revenue $2,211.343314 $1,809.805467 $1,274.250385
Gross profit $264.322778 $199.927176 $146.374585
Operating activities
Research & development
Selling, general & administrative $11.564285 $13.444222 $11.985807
Total operating expenses $12.174007 $13.932721 $12.432182
Operating income $252.148771 $185.994455 $133.942403
Income from continuing operations
EBIT $253.975815 $188.313069 $200.092618
Income tax expense $31.736333 $9.174859 $32.62771
Interest expense $172.692768 $152.945558 $74.555096
Net income
Net income $49.546714 $26.192652 $92.909812
Income (for common shares) $49.546714 $26.192652 $92.909812

Cash flows

XSLX
XSLX
(in millions USD) 30 Sep 2019 30 Jun 2019 31 Mar 2019 31 Dec 2018
Net income -$24.004457 $12.589187 $6.380579 $9.500489
Operating activities
Depreciation $0.330859 $0.172799 $0.487072 $0.509867
Business acquisitions & disposals
Stock-based compensation $0.021456
Total cash flows from operations $62.360833 -$35.543907 -$96.71394 -$95.6813
Investing activities
Capital expenditures -$0.002281 -$0.261484 -$0.0628 $0.345629
Investments -$202.8024
Total cash flows from investing -$202.804681 -$0.261484 -$0.0628 $0.345629
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $77.400335 $57.308486 $143.166041 $83.6223
Total cash flows from financing $79.588793 $57.320517 $140.965552 $78.242126
Effect of exchange rate -$52.988697 $91.001157 -$38.694621 $1.151102
Change in cash and equivalents -$113.843752 $112.516283 $5.494191 -$15.942443
(in millions USD) 2018 2017 2016
Net income $49.546714 $26.192652 $92.909812
Operating activities
Depreciation $1.726916 $1.648938 $1.415067
Business acquisitions & disposals $0.08278
Stock-based compensation $0.021456 $0.033014 $0.044572
Total cash flows from operations $365.670792 -$25.749914 -$74.007221
Investing activities
Capital expenditures -$0.145507 -$1.241172 $150.657383
Investments -$551.95895 -$1,913.618152
Total cash flows from investing -$0.145507 -$553.200122 -$1,762.877989
Financing activities
Dividends paid
Sale and purchase of stock $0.113562
Net borrowings -$355.613839 $519.993493 $1,901.988229
Total cash flows from financing -$367.572979 $560.108415 $1,856.513057
Effect of exchange rate -$3.078755 $2.505553 -$1.395223
Change in cash and equivalents -$5.126449 -$16.336068 $18.232624